Oxygenta Pharmaceutical share news, announcements and annual reports
BSE: 524636Pharmaceuticals & BiotechnologySmall Cap
OXYGENTA PHARMACEUTICAL LIMITED · Face value ₹10 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Oct 1994
Last close ₹47.00down ₹0.41 (0.86%)
Share price at the BSE close on 2 Nov 2026. Previous close ₹47.41.
2 Nov: open ₹45.16, high ₹47.65, low ₹45.16
52-week range of traded prices to 2 Nov 2026
₹43.00Low, 11 Jun 2026₹71.59High, 12 Aug 2026
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹174 Cr2,423rd largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- Lossover the last 12 months
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- Net worth zero or below
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business.
- Net worth zero or below
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- −15.1%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- Net worth zero or below
- Volume, BSEVolume. Shares traded on the last trading day. Volume in the glossary
- 5,485
Oxygenta Pharmaceutical routine notices
126 filed, newest first. Page 3 of 3.
Sep 2019
Jun 2019
May 2019
Apr 2019
3 Apr · Routine
Feb 2019
Nov 2018
Aug 2018
May 2018
Nov 2017
Sep 2017
Aug 2017
Feb 2017
Nov 2016
Sep 2016
Aug 2016
May 2016
19 May · Routine
Meeting of Board of Directors of the Company will be held on May 30, 2016, inter alia, to consider the Audited Financial Results for the Quarter ....
Feb 2016
3 Feb · Routine
Meeting of Board of Directors of the Company will be held on February 13, 2016, inter alia, to consider and take on record the Un-Audited Financial ....
Nov 2015
2 Nov · Routine
Meeting of Board of Directors of the Company will be held on November 14, 2015, inter alia, to consider and take on record the Un-Audited Financial ....
Aug 2015
2 Aug · Routine
Meeting of Board of Directors of the Company will be held on August 13, 2015, inter alia, to consider and take on record the Un-Audited Financial ....
May 2015
20 May · Routine
Meeting of the Board of Directors of the Company will be held on May 30, 2015, inter alia, to consider and take on record the Audited Financial Result ....
Feb 2015
2 Feb · Routine
Meeting of Board of Directors of the Company will be held on February 14, 2015, inter alia, to consider and take on record the Un-Audited Financial ....
Nov 2014
5 Nov · Routine
Meeting of Board of Directors of the Company will be held on November 14, 2014, inter alia, to consider and take on record the Un-Audited Financial ....
Jul 2014
31 Jul · Routine
Trading Window would remain closed from August 07, 2014 to August 14, 2014, both days inclusive, for the following categories (including dependents) ....